Serological Detection of Antibodies Against Mycoplasma bovis Infection by Competitive Enzyme-Linked Immunosorbent Assay (cELISA)
Veterinary Sciences · 25.07.2026 · 13 (8) · 741
DOI: 10.3390/vetsci13080741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Sciences, online erschienen am 25.07.2026. Verfasst von Wentao Fei und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Agriculture Research System, National Key Research and Development Program of China, Chinese Agricultural Research System.
Abstract (Originalsprache)
Mycoplasma bovis (M. bovis) is a major pathogen in cattle, primarily responsible for bovine respiratory disease complex (BRDC). Characterized by high infectivity and morbidity, M. bovis spreads rapidly within herds and is challenging to control and eradicate, underscoring the need for early and accurate diagnosis. To address this, we developed a competitive enzyme-linked immunosorbent assay (cELISA) for detecting M. bovis-specific antibodies in bovine sera. The assay uses recombinant MbovP579 protein (1 μg/mL) as the coating antigen and an HRP-conjugated 1A2 monoclonal antibody against MbovP579 (mAb, 0.35 μg/mL) as the competitor. With a cut-off value of 40.69% (percentage inhibition, PI), the cELISA demonstrated apparent sensitivity (90%; 95% CI: 78.64–95.65%) and specificity (96.15%; 95% CI: 90.53–98.49%) using the known background positive and negative sera. In addition, it yielded 100% positivity (9/9) against sera collected from 21 days post-immunization. The assay showed no cross-reactivity with other Mycoplasma species or two common bovine bacterial pathogens, confirming its high specificity. The intra- and inter-assay coefficients of variation (CVs) were below 10%. In clinical evaluations, this cELISA generated a 55.57% positivity rate for field samples (n = 1069) and exhibited 90.46% overall agreement (967/1069; 95% CI: 88.54–92.15%) with the commercial indirect ELISA kit, demonstrating strong diagnostic consistency. Discrepant specimens were further analyzed by a metabolic inhibition test (MIT), which suggested improved specificity, although further validation is required of this cELISA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.
- Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture and Rural Affairs, Huazhong Agricultural University, Wuhan 430070, China.
- Hubei Hongshan Laboratory, Huazhong Agricultural University, Wuhan 430070, China.
- Wuhan Keqian Biology Co., Ltd., Wuhan 430206, China.
ORCID-Profile: Yingyu Chen
Förderung
- China Agriculture Research System
- National Key Research and Development Program of China
- Chinese Agricultural Research System
Zitieren
APA
Fei, W., Yang, L., Zhao, Y., Xiang, Z., Fang, C., Chen, Y., Hu, C., & Guo, A. (2026). Serological Detection of Antibodies Against Mycoplasma bovis Infection by Competitive Enzyme-Linked Immunosorbent Assay (cELISA). Veterinary Sciences, 13(8), 741. https://doi.org/10.3390/vetsci13080741
Vancouver
Fei W, Yang L, Zhao Y, Xiang Z, Fang C, Chen Y, et al. Serological Detection of Antibodies Against Mycoplasma bovis Infection by Competitive Enzyme-Linked Immunosorbent Assay (cELISA). Veterinary Sciences. 2026;13(8):741. doi:10.3390/vetsci13080741
BibTeX
@article{Fei2026,
author = {Fei, Wentao and Yang, Li and Zhao, Yuhao and Xiang, Zhijie and Fang, Chengwei and Chen, Yingyu and Hu, Changmin and Guo, Aizhen},
title = {Serological Detection of Antibodies Against Mycoplasma bovis Infection by Competitive Enzyme-Linked Immunosorbent Assay (cELISA)},
journal = {Veterinary Sciences},
year = {2026},
volume = {13},
number = {8},
pages = {741},
doi = {10.3390/vetsci13080741}
}
EUVIMED